Overview
The 25th annual Autumn Update will feature expert faculty presenting on the latest topics in the treatment and prevention of HIV, with the goal of providing practitioners with the knowledge, skills, and resources they need to continue to deliver quality care to patients infected and affected by HIV.
We look forward to another great program and to seeing you all in beautiful Lake Tahoe.
Learning Objectives
Following the completion of this activity, participants should be able to:
- Discuss key updates in HIV medicine and related comorbidities based on recent conference data
- Review current approaches to the diagnosis of fungal infections
- Optimize antifungal therapeutic strategies for major fungal infections in HIV care
- Identify three causes of death that are direct outcomes of poor mental health among people with HIV
- Describe various life-threatening emergencies that present as changes in mental status among people with HIV
- Address mental health problems as a component of all HIV-related prevention, care and treatment approaches
- Apply recent data on Doxycycline Post-Exposure Prophylaxis (DOXY PEP) and Doxy PrEP (Pre-Exposure Prophylaxis) to clinical practice
- Explain the difference between PEP and PrEP Utilize a PEP to PrEP strategy for HIV prevention Explain updates on long-acting injectable PrEP
- List recent prevention strategies using doxycycline
- Consider the emergence of multi drug-resistant gonorrhea
- Identify mpox as a sexually transmitted infection, incorporating vaccinations and treatment
- Illustrate unusual presentations of syphilis and consider the utility of rapid, at-home syphilis tests
- Develop a process to screen for social determinants of health as a method to help improve linkage and retention in care
- Identify stigma as a barrier to linkage and retention in care
- Utilize person-first language in communications with clients
- Explain how synthetic substances relate to one another in the experience of consumption and in public health impact, primarily HIV
- Explain emerging treatment options and ongoing clinical research around the combined treatment of substance use disorder and HIV
- Explore the latest evidence on how different ART regimens influence weight gain and the development of metabolic disorders in people with HIV
- Implement evidence-based strategies for prevention and management of ART-related weight gain and associated metabolic disorder
- Describe current treatment principles in coinfected patients
- Review HBV vaccine strategies
Who Should Attend
Physicians, physician assistants, nurse practitioners, nurses, pharmacists, mental health providers, public health professionals, administrators, all members of the care team and other care providers are encouraged to attend.
Registration
The per-participant registration fee is $275 and includes two breakfasts, one lunch, CME/CE certificate, and access to electronic handouts.
The conference registration deadline is November 1, 2024. Register early, as space is limited.
For additional information, multiple registrants, or to pay-by-check, please call (775) 784-4791 or email skgeorge@med.unr.edu.
Program Support
This program is supported, in part, by the Pacific AIDS Education and Training Center - Nevada.
The PAETC-NV is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $4,305,236. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit HRSA.gov.
Cancellation Policy
Cancellations received by November 1, 2024 will receive a full refund less a $50 administrative fee. Cancellations after November 1, 2024 are non-refundable. For additional information, please contact (775) 784-4791 or cme@med.unr.edu.